{"id":29888,"date":"2013-11-06T12:00:42","date_gmt":"2013-11-06T11:00:42","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmj\/?p=29888"},"modified":"2013-11-06T12:00:42","modified_gmt":"2013-11-06T11:00:42","slug":"jim-murray-the-eu-transparency-and-access-to-clinical-trial-results","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/","title":{"rendered":"Jim Murray: The EU, transparency, and access to clinical trial results"},"content":{"rendered":"<p><a href=\"https:\/\/blogs.bmj.com\/bmj\/2013\/10\/31\/jim-murray-the-emas-efforts-to-widen-access-to-clinical-trial-results\/jim_murray\/\" rel=\"attachment wp-att-29744\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-thumbnail wp-image-29744\" alt=\"jim_murray\" src=\"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray-150x150.jpg\" width=\"150\" height=\"150\" \/><\/a>How is the EU involved in transparency and access to clinical trial results? Many readers will know this already, but perhaps not all. For obvious reasons, health professionals have tended to focus on the national and they might not all appreciate the strength of the \u201cside-wind\u201d blowing from the EU.<\/p>\n<p>The EU was formed on the basis of a common market, an area of free movement of people, capital, and goods, and in this context \u201cgoods\u201d included pharmaceuticals. Thus the EU has competence, within limits, to make laws coordinating or \u201charmonising\u201d rules on the authorisation of medicines and clinical trials, and to set up the European Medicines Agency.\u00a0 Without at least some common rules there cannot be a common market in pharmaceuticals.<!--more--><\/p>\n<p>This partly explains why the industry division (now DG Enterprise) of the European Commission was given responsibility for pharmaceuticals\u2014one industrial product among many for which a single market would be developed.\u00a0 The same DG was also responsible for promoting the European pharmaceutical industry, and it showed. A major communication on medicines policy in 2008 was entitled, \u201c<em>Safe, Innovative, and Accessible Medicines: a renewed vision for the <strong>Pharmaceutical Sector<\/strong><\/em>\u201d (my emphasis).<\/p>\n<p>In 2010, at last, responsibility for medicines was passed to the general directorate for health and consumers, DG Sanco.\u00a0 Unfortunately, the mind-set in DG Sanco does not appear to me to be very different, so far, from that of their predecessors in enterprise, apart perhaps from consulting more widely. There were no signs of new thinking in the DG Sanco management plans and roadmaps for 2011 and 2012.\u00a0 The proposed revision of the Clinical Trials Directive was justified on the grounds of reducing unnecessary administrative burdens, a key (and valid) industry demand, but DG Sanco has shown little or no acknowledgement of any need to improve the quality, transparency, and rigour of the science and evidence base for medicines policy. Among senior officials,\u00a0 I can detect no sense of \u201cownership\u201d of such issues as publication bias, access to clinical trials results, authorship, and the like.<\/p>\n<p>The European Parliament and the European Medicines Agency have tried to move forward on transparency, but DG Sanco seems to be lagging behind. It is not clear if they will support the parliament\u2019s initiative on transparency and they do not appear to have little enthusiasm for the efforts of the European Medicines Agency either.<\/p>\n<p><em>Competing interests: I declare that that I have read and understood the BMJ Group policy on declaration of interests and I have no relevant interests to declare.<\/em><\/p>\n<p><em><strong>Jim Murray<\/strong> is a former director of BEUC the European Consumers Organisation, having previously been the first director of the Office of Consumer Affairs and Fair Trade in Ireland. He writes here in a personal capacity. During his time with BEUC, he was a founder and one time president of the Transatlantic Consumer Dialogue. Currently he is a member of the European Commission\u2019s High Level Group on Administrative Burdens, and president of the European Foundation for Financial Inclusion.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>How is the EU involved in transparency and access to clinical trial results? Many readers will know this already, but perhaps not all. For obvious reasons, health professionals have tended [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/\">More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5746,5744],"tags":[],"class_list":["post-29888","post","type-post","status-publish","format-standard","hentry","category-jim-murray","category-open-data"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Jim Murray: The EU, transparency, and access to clinical trial results - The BMJ<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jim Murray: The EU, transparency, and access to clinical trial results - The BMJ\" \/>\n<meta property=\"og:description\" content=\"How is the EU involved in transparency and access to clinical trial results? Many readers will know this already, but perhaps not all. For obvious reasons, health professionals have tended [...]More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"The BMJ\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bmjdotcom\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-11-06T11:00:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray-150x150.jpg\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:site\" content=\"@bmj_latest\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"Jim Murray: The EU, transparency, and access to clinical trial results\",\"datePublished\":\"2013-11-06T11:00:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/\"},\"wordCount\":506,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2013\\\/10\\\/jim_murray-150x150.jpg\",\"articleSection\":[\"Jim Murray\",\"Open data\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/\",\"name\":\"Jim Murray: The EU, transparency, and access to clinical trial results - The BMJ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2013\\\/10\\\/jim_murray-150x150.jpg\",\"datePublished\":\"2013-11-06T11:00:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2013\\\/10\\\/jim_murray.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2013\\\/10\\\/jim_murray.jpg\",\"width\":299,\"height\":466},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/2013\\\/11\\\/06\\\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jim Murray: The EU, transparency, and access to clinical trial results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"name\":\"The BMJ\",\"description\":\"Helping doctors make better decisions.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#organization\",\"name\":\"The BMJ\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/files\\\/2018\\\/05\\\/The-BMJ-logo.jpg\",\"width\":852,\"height\":568,\"caption\":\"The BMJ\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bmjdotcom\\\/\",\"https:\\\/\\\/x.com\\\/bmj_latest\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmj\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jim Murray: The EU, transparency, and access to clinical trial results - The BMJ","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/","og_locale":"en_US","og_type":"article","og_title":"Jim Murray: The EU, transparency, and access to clinical trial results - The BMJ","og_description":"How is the EU involved in transparency and access to clinical trial results? Many readers will know this already, but perhaps not all. For obvious reasons, health professionals have tended [...]More...","og_url":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/","og_site_name":"The BMJ","article_publisher":"https:\/\/www.facebook.com\/bmjdotcom\/","article_published_time":"2013-11-06T11:00:42+00:00","og_image":[{"url":"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray-150x150.jpg","type":"","width":"","height":""}],"author":"BMJ","twitter_card":"summary_large_image","twitter_creator":"@bmj_latest","twitter_site":"@bmj_latest","twitter_misc":{"Written by":"BMJ","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"Jim Murray: The EU, transparency, and access to clinical trial results","datePublished":"2013-11-06T11:00:42+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/"},"wordCount":506,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray-150x150.jpg","articleSection":["Jim Murray","Open data"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/","url":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/","name":"Jim Murray: The EU, transparency, and access to clinical trial results - The BMJ","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray-150x150.jpg","datePublished":"2013-11-06T11:00:42+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2013\/10\/jim_murray.jpg","width":299,"height":466},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmj\/2013\/11\/06\/jim-murray-the-eu-transparency-and-access-to-clinical-trial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmj\/"},{"@type":"ListItem","position":2,"name":"Jim Murray: The EU, transparency, and access to clinical trial results"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmj\/#website","url":"https:\/\/blogs.bmj.com\/bmj\/","name":"The BMJ","description":"Helping doctors make better decisions.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmj\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmj\/#organization","name":"The BMJ","url":"https:\/\/blogs.bmj.com\/bmj\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","contentUrl":"https:\/\/blogs.bmj.com\/bmj\/files\/2018\/05\/The-BMJ-logo.jpg","width":852,"height":568,"caption":"The BMJ"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bmjdotcom\/","https:\/\/x.com\/bmj_latest"]},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmj\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmj\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/29888","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/comments?post=29888"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/posts\/29888\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/media?parent=29888"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/categories?post=29888"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmj\/wp-json\/wp\/v2\/tags?post=29888"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}